DARE - Dare Bioscience GAAP EPS of -$0.10 beats by $0.04 May, 12 2022 08:18 AM Dare Bioscience Inc. Dare Bioscience press release (NASDAQ:DARE): Q1 GAAP EPS of -$0.10 beats by $0.04. $39.3 million in cash and cash equivalents at March 31, 2022 For further details see: Dare Bioscience GAAP EPS of -$0.10 beats by $0.04